Molecular and Anatomic Imaging of Neuroendocrine Tumors
Surgical Oncology Clinics of North America(2022)
摘要
Positron emission tomography (PET) with somatostatin receptor (SSTR) ligands has taken the lead in the imaging of neuroendocrine tumors (NETs). In this article, we review the role of SSTR PET scan in the management of NETs, including the indications for the scan, pitfalls in interpretation, and imaging selection criteria for peptide receptor radionuclide therapy. We also discuss the complementary role of fluorodeoxyglucose PET particularly for patients with high-grade disease.
更多查看译文
关键词
Neuroendocrine tumor,Somatostatin receptor,Positron emission tomography,Imaging,Peptide receptor radionuclide therapy,Appropriate use,Management
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要